Tritium (³H) Catalog Number Listings : MT 1601 - MT 1699

MT 1601 - MT 1620

MT 1621 - MT 1640

MT 1641 - MT 1660

MT 1661 - MT 1680

MT 1681 - MT 1700

---

MT 1601 - MT 1620

MT 1601	Ribavirin 5'-monophosphate, diammonium salt, [3H]-
MT 1602	3TC, [3H]-
MT 1602	(-)-β-L-2',3'-Dideoxy-3'-thiacytidine monophosphate, [3H]-
MT 1602	Lamivudine-MP, [3H]-
MT 1605	(-)-β-2',3'-Dideoxy-5-fluoro-3'-thiacytidine, [6-3H]-
MT 1606	Resveratrol, [3H]-
MT 1608	Adefovir dipivoxil, [adenine-8-3H]-
MT 1608	Bis(pivaloyloxymethyl)9-(2-Phosphonylmethoxyethyl) adenine, [adenine-8-3H]-
MT 1609	Cytidine 5'-diphosphocholine, disodium salt, [5-3H]-
MT 1611	2-Deoxy-D-glucose, [1-3H(N)]-
MT 1612	2,3-Dihydroisoflavone, [2,3-3H]-
MT 1613	4-Benzoylbenzoic acid, [ring-3H]-
MT 1614	3-Methylcholanthrene, [3H]-
MT 1615	Triphenylphosphine, [3H]-
MT 1616	Clenbuterol, [3H]-
MT 1618	4,7-Dichloroquinoline, [3H]-
MT 1619	Oleandrin, [3H]-
MT 1620	Warfarin, [phenyl-4-3H]-

Back to Top

---

MT 1621 - MT 1640

MT 1621	4-(Methylnitrosamine)-1-(3-pyridyl)-1-butanone, [pyridyl-5-3H]-
MT 1621	NNK, [pyridyl-5-3H]-; (4-(Methylnitrosamine)-1-(3-pyridyl)-1-butanone, [pyridyl-5-3H]-)
MT 1622	N'-Nitrosonornicotine, [pyridyl-5-3H]-
MT 1622	NNN, [pyridyl-5-3H]-; (N'-Nitrosonornicotine, [pyridyl-5-3H]-)
MT 1623	Myosmine, [pyridyl-5-3H]-
MT 1624	Hexadecane, [1,2-3H]-   Discontinued
MT 1624S	Hexadecane, [1,2-3H]- (for use as a liquid scintillation standard)   Discontinued
MT 1625	Phytol, [1-3H]-
MT 1626	Rifampin, [4-methylpiperazine-3H]-
MT 1626M	Rifampin, [4-methylpiperazine-3H]-
MT 1627	(R)-Warfarin, [phenyl-4-3H]-
MT 1628	(S)-Warfarin, [phenyl-4-3H]-
MT 1629	Bis(pivaloyloxymethyl)-9-[2-(phosphonomethoxy)propyl]adenine, [adenine-2,8-3H]-
MT 1629	Bis-POM-PMPA, [adenine-2,8-3H]-
MT 1629	Tenofovir dipivoxil, [adenine-2,8-3H]-
MT 1633	all trans-Geranyl geraniol, [1-3H]-
MT 1636	Isopentenol, [1-3H]-
MT 1639	Metoprolol, [3H]-

Back to Top

---

MT 1641 - MT 1660

MT 1641	Arachidonyl coenzyme A, [arachidonyl-5,6,8,9,11,12,14,15-3H]-
MT 1644	Chloroethylnitrosourea, [chloroethyl-1,2-3H]-
MT 1645	D-chiro-Inositol, [3-3H]-    Discontinued
MT 1646	Paclitaxel, [2,6-benzamido-3H]-   (20-40 Ci/mmol)
MT 1647	Amprenavir, [3H]-
MT 1648	Lopinavir, [3H]-
MT 1649	Oleoyl Coenzyme A, [oleoyl-9,10-3H]-
MT 1650	Phytanic acid, [2,3-3H]-    (Discontinued)
MT 1651	3'-Deoxycytidine, [5-3H(N)]-
MT 1654	L-Valine, [3H]-
MT 1655	4'-Thio-arabinofuranosyl cytosine, [5-3H]-; (T-araC, [5-3H]-)
MT 1656	Benzo[b]phenanthro[2,3-d]thiophene, [3H]-
MT 1658	4'-Thio-2'-deoxycytidine, [5-3H]-
MT 1659	5-Iodouracil dioxolane, [5'-3H]-

Back to Top

---

MT 1661 - MT 1680

MT 1661	2-Benzamido-4-methoxy-4-oxobutanoic acid, [3H]-
MT 1663	9-(2-Phosphonylmethoxypropyl)-2,4-diaminopurine, [8-3H]-
MT 1664	9-(2-Phosphonylmethoxyethyl)-2,4-diaminopurine, [8-3H]-
MT 1665	p-Dimethylaminobenzaldehyde, [3-3H]-
MT 1666	Hexahydroxycolupulone, [3H]-
MT 1667	D-Alanyl-D,L-phenylalanine, [phenyl-4-3H]-
MT 1668	2,4-Diaminopurine dioxolane, [5'-3H]-; (DAPD, [5'-3H]-)
MT 1671	L-Glutamine, [3,4-3H(N)]-
MT 1672	β-L-Dioxolane cytosine, [5-3H]-
MT 1673	Paromomycin, [3H]-
MT 1675	D-allo-Inositol, [3H]-    Discontinued
MT 1676	5-Aza 2'-deoxycytidine, [6-3H]-; (Decitabine, [6-3H]-)
MT 1677	β-L-2',3'-Dideoxyadenosine, [2',3',8-3H]-
MT 1678	(S)-N'-Nitrosonornicotine, [pyridyl-5-3H]-
MT 1679	(R)-N'-Nitrosonornicotine, [pyridyl-5-3H]-

Back to Top

---

MT 1681 - MT 1699

MT 1681	2'-Deoxy-ß-L-cytidine, [5,6-3H]-
MT 1682	2'-Deoxy-ß-L-adenosine, [2,8-3H]-
MT 1683	Fluocinonide, [3H]-
MT 1685	β-L-2'-Deoxyinosine, [8-3H]-
MT 1686	2,6-Dimethylaniline, [4-3H]-
MT 1687	(-)-β-D-2,4-Diaminopurine dioxolane, [8-3H]-; ((-)-DAPD, [8-3H]-)
MT 1689	Cytosine dioxolane, [3H]-
MT 1691	Bis-POM PMPDAP, [diaminopurine-8-3H]-
MT 1692	β-L-Cytidine, [3H]-
MT 1693	β-L-Guanosine, [8-3H]-
MT 1694	L-Uridine, [3H]-
MT 1695	2-Fluoro-2'-deoxyadenosine, [8-3H]-
MT 1696	Benzanthrone, [3H]-
MT 1697	Thiamine diphosphate, [3H]-; (Thiamine pyrophosphate, [3H]-; Cocarboxylase, [3H]-)
MT 1698	N-Methyl-N-pentylamine hydrochloride, [3H]-

Back to Top

---